Liang Aidi, Huang Jiapeng, He Xinyi, Tang Xinru, Xu Xuncan, Chen Ming, Meng Lei, Lin Canbin
Department of Urology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Department of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China.
Braz J Med Biol Res. 2025 Feb 3;58:e13507. doi: 10.1590/1414-431X2024e13507. eCollection 2025.
It has been confirmed that the expression of miR-501-3p is closely related to the behavior of several cancers. This study aimed to elucidate the effects of miR-501-3p/SPC24 axis on the behavior of renal cancer cells and to identify its prognostic value in renal cancer. First, the expression of miR-501-3p in the renal cell carcinoma (RCC) cell line was detected using real-time quantitative polymerase chain reaction (RT-qPCR). Second, cell function identification experiments were performed, including CCK-8, scratch, transwell invasion, and flow cytometry assays. Several databases were applied to explore the possible mechanism of miR-501-3p tumor suppressor effect in RCC. To explore the value of miR-501-3p/SPC24 axis in predicting renal cancer patient overall survival (OS), GEPIA (http://gepia.cancer-pku.cn/index.html) was used. Finally, western blot was performed to detect the expression level of SPC24 in renal cancer cells predicted by bioinformatics analysis. Dual-Luciferase Reporter Assay was used to verify if SPC24 is a target of mir-501-3p. MiR-501-3p was found to be down-regulated in cancer cells and tissues and to play a role in suppressing tumor cell proliferation, cell viability, cell migration, and cell invasion, while promoting apoptosis. We also found that high expression levels of SPC24 were associated with shorter OS time in patients diagnosed with renal cell carcinoma. In addition, the results of TCGA data analysis and western blot showed that the tumor suppressor effect of miR-501-3p may be achieved by targeting SPC24. The MiR-501-3p/SPC24 axis affects cell proliferation, migration, invasion, apoptosis, and prognosis in renal cell carcinoma.
已证实miR-501-3p的表达与多种癌症的行为密切相关。本研究旨在阐明miR-501-3p/SPC24轴对肾癌细胞行为的影响,并确定其在肾癌中的预后价值。首先,使用实时定量聚合酶链反应(RT-qPCR)检测肾细胞癌(RCC)细胞系中miR-501-3p的表达。其次,进行细胞功能鉴定实验,包括CCK-8、划痕、Transwell侵袭和流式细胞术检测。应用多个数据库探索miR-501-3p在RCC中发挥肿瘤抑制作用的可能机制。为了探索miR-501-3p/SPC24轴在预测肾癌患者总生存期(OS)中的价值,使用了GEPIA(http://gepia.cancer-pku.cn/index.html)。最后,进行蛋白质免疫印迹法检测生物信息学分析预测的肾癌细胞中SPC24的表达水平。使用双荧光素酶报告基因检测法验证SPC24是否为mir-501-3p的靶标。发现miR-501-3p在癌细胞和组织中表达下调,并在抑制肿瘤细胞增殖、细胞活力、细胞迁移和细胞侵袭,同时促进细胞凋亡方面发挥作用。我们还发现,SPC24的高表达与肾细胞癌患者较短的OS时间相关。此外,TCGA数据分析和蛋白质免疫印迹法的结果表明,miR-501-3p的肿瘤抑制作用可能是通过靶向SPC24实现的。MiR-501-3p/SPC24轴影响肾细胞癌的细胞增殖、迁移、侵袭、凋亡和预后。